Menu

Blog

Archive for the ‘business’ category: Page 253

Jan 29, 2017

Choosing a New System Architecture

Posted by in categories: business, food, sustainability

The food retail, foodservice and industrial cooling industries are in the midst of a momentous transition in refrigeration system architectures. Regulations are driving the need to implement sustainable systems with options growing exponentially. Emerson’s natural refrigerant expert, Andre Patenaude, provides advice on the best alternatives to future proof your system.

To get to what many call the “end game” of achieving compliance and meeting corporate sustainability objectives, more businesses are looking at systems based on natural refrigerants to help them achieve these goals.

The term “natural refrigerant” refers to substances that naturally occur in the environment. Unlike the synthetic refrigerants that have commonly been used in refrigeration applications — including hydrofluorocarbons (HFCs) and chlorofluorocarbons (CFCs) — ammonia (NH3 or refrigerant name R-717), propane (refrigerant name R-290) and carbon dioxide (CO2 or refrigerant name R-744) are three naturally occurring refrigerants that pose very little threat to the environment.

Continue reading “Choosing a New System Architecture” »

Jan 20, 2017

Introducing the European Bots Landscape

Posted by in categories: business, robotics/AI

Over the past half year, bots have been a widely discussed topic. Experts and the media heavily discussed all the possible benefits, the future, and the value bots could create for businesses and consumers. Arguably, the tipping point was Facebook’s F8 conference in April. Since then, many developers and consumers have massively experimented with bots and tested their limits to find the most suitable use cases for bots.

During this trend, the U.S. market has proven to be highly interested in bots. Several published surveys are showing strong U.S. bot companies, as you can see in VentureBeat’s Bots Landscape. But Europe is not far behind.

Read more

Jan 20, 2017

Bristol professor reveals quantum power behind new industrial revolution to world leaders at Davos

Posted by in categories: business, computing, quantum physics

As the world’s political and business leaders gathered at Davos, it fell to a professor from the University of Bristol to reveal to them the full implications of a ‘fourth industrial revolution’.

Professor Jeremy O’Brien, director of the Centre for Quantum Photonics at the University of Bristol, addressed some of the most powerful people in the world yesterday at the annual meeting of the World Economic Forum (WEF) in Davos, Switzerland – to tell them just how rapidly quantum computers could change the world.

Part of the European Research Council (ERC) Ideas Lab delegation, Professor O’Brien has been actively involved with the WEF over the past few years and recently took on the role of co-chair of the Global Future Council on Computing. Last year he presented a talk on working towards a quantum computer discussing the future of computing and how new fields of computer sciences are paving the way for the next digital revolution.

Continue reading “Bristol professor reveals quantum power behind new industrial revolution to world leaders at Davos” »

Jan 8, 2017

Government testing online grocery shopping for food stamp participants

Posted by in categories: business, food, government, health

Interesting approach.


Families who rely on food stamps may not be left out of the future of grocery shopping after all.

The pilot, which will run for two years, will launch on Shop.safeway.com in August.

Continue reading “Government testing online grocery shopping for food stamp participants” »

Jan 5, 2017

The Future Of Encryption

Posted by in categories: business, cybercrime/malcode, encryption, engineering, internet, quantum physics

QC in the mainstream is definitely viable less than 7 yrs. and possible within 5 yrs. However, I have a friend who even believes we’re looking at 3 years.


Internet security, once considered to be strictly in the domain of the wonkiest tech experts, has become central to public discourse over the past year. Besides the attacks on the DNC, even tech savvy business like Snapchat, Oracle and Verizon Enterprise Solutions have had significant breaches in the last year.

For the most part, these attacks were preventable. Often, hackers use a technique called social engineering, to trick people into allowing them into a system. Other times, they exploit a vulnerability in software to give them access to confidential data. In most cases, more stringent procedures can prevent attacks.

Continue reading “The Future Of Encryption” »

Jan 5, 2017

Synthego bags $41M to grow CRISPR synthetic RNA kit biz

Posted by in categories: bioengineering, biotech/medical, business, robotics/AI

Nice.


Synthetic RNA kit business Synthego has raised $41 million to step up its efforts to make CRISPR gene editing easier and more accurate. The West Coast startup relied heavily on tech VCs for the cash, but also gained validation from having CRISPR pioneer Jennifer Doudna invest in its business.

Redwood City, CA-based Synthego exited stealth in August, four years after it was set up by two former SpaceX computer engineers. In those early years, which were bankrolled by an $8.3 million investment in 2013, Synthego established an automated manufacturing process for guide RNA products that it thinks sets it apart from larger competitors in terms of cost, turnaround time and editing efficiency.

Continue reading “Synthego bags $41M to grow CRISPR synthetic RNA kit biz” »

Jan 5, 2017

Bioquark Inc. Announces Approval of Bioquantine Food Ingredients in Eurasian Customs Union

Posted by in categories: aging, biotech/medical, business, disruptive technology, food, genetics, health, life extension, science, transhumanism

Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, announced the commercial approval of naturally derived Bioquantine food ingredients in the Eurasian Customs Union (formerly known as the Customs Union of Belarus, Kazakhstan, and Russia). Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, collaborated with Bioquark Inc. on the regulatory approvals.

green-cell

“We are very excited about this successful regulatory approval,” said Ira S. Pastor, CEO, Bioquark Inc. “The commercialization of Bioquantine food ingredients, including functional foods, drinks, and dietary supplements, represents another important step in our continued evolution as a company focused on a broad range of products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

Continue reading “Bioquark Inc. Announces Approval of Bioquantine Food Ingredients in Eurasian Customs Union” »

Jan 4, 2017

NASA Should Build a Superhighway in Space

Posted by in categories: business, space

NASA needs to get out of the rocket business and start doing what it’s uniquely qualified for.

Read more

Jan 2, 2017

Let’s cut to the chase – there have never been times as uncertain as these in the world of business

Posted by in categories: business, robotics/AI, singularity

There is no written rule-book to follow when it comes to career survival. The “Future of Work” is about making ourselves employable in a workforce where the priority of business leaders is to invest in automation and digital technology, more than training and developing their own workforces.

As our soon-to-be-released State of Operations and Outsourcing 2017 study, conducted in conjunction with KPMG across 454 major enterprise buyers globally, shows a dramatic shift in priorities from senior managers (SVPs and above), where 43% are earmarking significant investment in robotic automation of processes, compared with only 28% placing a similar emphasis on training and change management. In fact, the same number of senior managers are as focused on cognitive computing as their own people … yes, folks, this is the singularity of enterprise operations, where cognitive computing now equals employees’ brains when it comes to investment!

Continue reading “Let’s cut to the chase – there have never been times as uncertain as these in the world of business” »

Dec 31, 2016

Gene therapy is here, and it could radically change modern medicine

Posted by in categories: biotech/medical, business

For a few lucky patients, 2016 was the year when gene therapy turned from promises to cures. The technology, long contemplated as a way to erase disease by revising people’s DNA, made big advances and began turning into a real business offering some of the world’s most expensive and revolutionary medicines.

So what is gene therapy, anyway? The US Food and Drug Administration says it’s any treatment in which a replacement gene is added to a person’s body or a disease-causing one is inactivated. That’s usually done by adding­­­­­­ new instructions to cells via billions of viruses stuffed with correct DNA strands.

It sounds complicated, and it is. Gene therapy was first tested in a person in 1990, but scary side effects turned the gene-fix idea into a scientific backwater. And the field hasn’t conquered all its problems. We started the year with the tale of Glybera, heralded as the first gene treatment ever approved that sought to correct an inherited gene error. Yet the drug came with an eye-popping price tag of $1 million and, dogged by questions over how well it works, has turned into a medical and commercial flop.

Continue reading “Gene therapy is here, and it could radically change modern medicine” »